PipelinePharma Logo

dimenhydrinate Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Singapore
GMP approvals
PICS
Manufacturer #20928

​Established in 1970, this Manufacturer is a CTD dossier owner and manufacturer with a global presence spanning over 5 countries and regions, including Brunei, Myanmar, Hong Kong, Seychelles, and Papua New Guinea. With a dedicated team of 11–50 employees, it operates GMP-certified facilities in Singapore, producing a diverse range of products including tablets, capsules, creams, balms, external liquids, and powder sachets. As a GMP manufacturer, it holds certifications such as cGMP and ISO 9001:2000, ensuring adherence to international quality standards. The Manufacturer's commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​

Manufacturer usually replies in 23 days

Dimenhydrinate is a pharmaceutical drug that is used to treat insomnia, vertigo and nausea. As a standalone drug, it is primarily marketed as dimenhydrinate tablets but is also available in liquid and suppository form. Depending on the formulation, it is can be administered orally, or by way of either intravenous or intramuscular injection. Dimenhydrinate is also commonly used as an ingredient in combination drugs, along with substances such as cinnarizine, pyridoxine, paracetamol, and others. Major suppliers of trade name dimenhydrinate medications include Pfizer, Sandoz, and Teva. On the other hand, suppliers Fresenius Kabi, Mylan are few of the distributors of generic versions of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.